Industry AI Adoption Leaderboard

Top AI-ready Manufacturing companies — 4,515 ranked

Ranked leaderboard of 4,515 Manufacturing companies by Meo AI adoption score.

4515

Companies Scored

Avg Adoption Score

Advanced

Top Stage

Which 4,515 ranked companies lead in AI adoption?

What is the average AI adoption score in the 4,515 ranked industry?
Who are the top 10 AI adopters in 4,515 ranked?

#	Company	Stage	Key Opportunity	Location
1	Red Nucleus	Advanced	Automated Clinical Trial Document Generation and Review	Yardley, Pennsylvania
2	Cellares	Advanced	Automated Clinical Trial Document Review and Data Extraction	South San Francisco, California
3	merck	Advanced	Accelerating drug discovery and development by using generative AI to design novel molecules and predict clinical trial outcomes.	rahway, New Jersey
4	the janssen pharmaceutical companies of johnson & johnson	Advanced	AI can dramatically accelerate drug discovery and clinical trial design by predicting molecular interactions and optimizing patient recruitment, reducing time-to-market for new therapies.	raritan, New Jersey
5	astra zeneca lp us	Advanced	AI can dramatically accelerate drug discovery and clinical trial design by predicting molecular interactions and optimizing patient recruitment, reducing time-to-market for new therapies.	wilmington, Delaware
6	pfizerpro	Advanced	AI can accelerate drug discovery and clinical trial optimization, reducing development timelines from years to months and saving billions in R&D costs.	new york, New York
7	starkindustries2, ltds.	Advanced	AI-driven molecular simulation and materials discovery can drastically accelerate R&D cycles and reduce costs for new nanotechnology products.	watertown, New York
8	pfizer	Advanced	AI can dramatically accelerate drug discovery by predicting molecular interactions and optimizing clinical trial design, potentially cutting years and billions from R&D timelines.	new york, New York
9	vertex pharmaceuticals	Advanced	AI can dramatically accelerate target identification and compound optimization for novel genetic disease therapies, compressing years of research into months.	boston, Massachusetts
10	monsanto company	Advanced	AI-driven predictive modeling can optimize the genetic selection and field trial process for new seed and trait development, dramatically accelerating R&D cycles and improving yield predictability under varying climate conditions.	st. louis, Missouri
11	msd	Advanced	AI can dramatically accelerate drug discovery and clinical trial design by predicting molecular interactions and optimizing patient recruitment, potentially saving billions in R&D costs and years in development timelines.	rahway, New Jersey
12	eli lilly and company	Advanced	AI can accelerate drug discovery by predicting molecular interactions and optimizing clinical trial design, dramatically reducing time-to-market for new therapies.	indianapolis, Indiana
13	Vanigent	Advanced	Automated Clinical Trial Patient Recruitment & Screening	Atlanta, Georgia
14	The Cary Company	Advanced	Automated Inventory Management and Replenishment Forecasting	Addison, Illinois
15	Amplity	Advanced	Automated Medical Information Request Handling	Langhorne, Pennsylvania
16	Lantheus	Advanced	Automated Clinical Trial Patient Recruitment and Screening	Bedford, Massachusetts
17	amgen	Advanced	AI can dramatically accelerate drug discovery and clinical trial design by predicting protein structures, identifying novel therapeutic targets, and optimizing patient recruitment, potentially cutting years and billions from R&D timelines.	thousand oaks, California
18	Walsworth	Advanced		Brookfield, Missouri
19	Myers Industries	Advanced		Akron, Ohio
20	MFA Oil	Advanced		Columbia, Missouri
21	IWCO	Advanced		Chanhassen, Minnesota
22	Resource Label Group	Advanced		Franklin, Tennessee
23	bristol myers squibb	Advanced	AI can accelerate drug discovery and clinical trials by predicting molecular interactions, optimizing trial design, and identifying patient cohorts, dramatically reducing the time and cost of bringing new therapies to market.	lawrence township, New Jersey
24	procter & gamble	Advanced	AI-driven demand sensing and dynamic supply chain optimization can significantly reduce stockouts and inventory costs across its global portfolio of fast-moving consumer goods.	cincinnati, Ohio
25	Alleguard	Advanced		brentwood, Tennessee
26	Takeda Oncology	Advanced		Cambridge, Massachusetts
27	avantor	Advanced	AI-driven supply chain optimization and predictive quality control for high-purity materials can reduce waste and improve on-time delivery.	radnor, Pennsylvania
28	RelaDyne	Advanced		Cincinnati, Ohio
29	NYSCC	Advanced		New York, New York
30	iff	Advanced	Accelerate novel flavor and fragrance molecule discovery with generative AI, cutting R&D cycle time by 30–50% while optimizing for cost, sustainability, and regulatory compliance.	new york, New York
31	Fagron US	Advanced	Automated Prior Authorization Processing	Austin, Texas
32	PBF Energy	Advanced		Parsippany-Troy Hills, New Jersey
33	itw	Advanced	Deploy AI-driven predictive maintenance across global manufacturing lines to reduce unplanned downtime and optimize equipment effectiveness.	,
34	ProVia	Advanced		Sugarcreek, Ohio
35	abbvie	Advanced	AI-driven target discovery and clinical trial optimization can dramatically accelerate drug development pipelines and reduce multi-billion-dollar R&D costs.	north chicago, Illinois
36	Federal	Moderate		Springfield, Illinois
37	Sinclair Oil	Moderate		, null
38	BEHR	Moderate		Santa Ana, California
39	Valvoline™ Global	Moderate		lexington, Kentucky
40	Libertycoke	Moderate		Philadelphia, Pennsylvania
41	North Sails	Moderate		Newport, Rhode Island
42	Mannington	Moderate		Salem, New Jersey
43	regeneron	Moderate	AI can accelerate Regeneron's core R&D by predicting drug-target interactions and patient response biomarkers, drastically reducing the time and cost of bringing new biologics to market.	tarrytown, New York
44	Prognos Health	Moderate	Automated Clinical Trial Patient Matching and Outreach	New York, New York
45	medivation	Moderate	Leveraging generative AI to accelerate clinical trial patient recruitment and optimize oncology drug trial protocols, reducing time-to-market by up to 30%.	new york, New York
46	dupont	Moderate	AI can accelerate the discovery and formulation of new sustainable materials by predicting molecular properties and optimizing synthesis pathways, drastically reducing R&D timelines.	wilmington, Delaware
47	sanofi genzyme	Moderate	AI can accelerate drug discovery for rare diseases by predicting molecular interactions and optimizing clinical trial design, drastically reducing development timelines and costs.	cambridge, Massachusetts
48	daiichi sankyo us	Moderate	AI can accelerate oncology drug discovery by predicting compound efficacy and optimizing clinical trial designs, reducing time-to-market for life-saving therapies.	basking ridge, New Jersey
49	gilead sciences	Moderate	AI can dramatically accelerate drug discovery and clinical trial design by predicting molecular interactions and identifying optimal patient cohorts.	foster city, California
50	bristol-myers squibb	Moderate	Leveraging generative AI to accelerate clinical trial document generation and regulatory submission drafting, reducing cycle times by 30-40% for a mid-market pharma firm.	seattle, Washington
51	egpi	Moderate	Leveraging AI for accelerated drug discovery and predictive analytics in clinical trials to reduce time-to-market and R&D costs.	torrance, California
52	thermo fisher scientific	Moderate	AI can accelerate drug discovery and diagnostics by analyzing vast genomic and proteomic datasets to identify novel biomarkers and therapeutic targets, dramatically reducing R&D timelines.	waltham, Massachusetts
53	johnson & johnson	Moderate	AI can accelerate drug discovery and clinical trials by predicting molecular interactions and optimizing patient recruitment, dramatically reducing time-to-market and R&D costs.	new brunswick, New Jersey
54	Atmus	Moderate		nashville, Tennessee
55	Voyant Beauty	Moderate		Lyons Township, Illinois
56	Lannett	Moderate		Philadelphia, Pennsylvania
57	PAHC	Moderate		Teaneck Township, New Jersey
58	dow	Moderate	AI-driven predictive maintenance and process optimization in large-scale chemical plants can significantly reduce unplanned downtime, improve yield, and enhance safety.	midland, Michigan
59	medformers	Moderate	Leverage AI for accelerated drug discovery and clinical trial optimization to reduce time-to-market and R&D costs.	new york, New York
60	Drug Plastics & Glass Co., Inc.	Moderate		boyertown, Pennsylvania
61	schering-plough research institute	Moderate	AI can accelerate drug discovery by predicting molecular interactions and optimizing clinical trial design, dramatically reducing time-to-market for new therapeutics.	kenilworth, New Jersey
62	TP Orthodontics	Moderate		La Porte, Indiana
63	celgene	Moderate	AI-driven drug discovery and clinical trial optimization can significantly accelerate time-to-market for novel therapies while reducing R&D costs.	summit, New Jersey
64	YAK MAT	Moderate		Columbia, Mississippi
65	Alaffia	Moderate		Olympia, Washington
66	milliporesigma	Moderate	AI can accelerate drug discovery and bioprocess optimization by predicting experimental outcomes, analyzing complex multi-omics data, and automating the design of novel reagents and assays.	burlington, Massachusetts
67	p&g pharmaceuticals	Moderate	AI-driven target discovery and clinical trial optimization can dramatically accelerate drug development cycles and reduce multi-billion-dollar R&D costs.	,
68	Sprague	Moderate		Portsmouth, New Hampshire
69	iveric bio, an astellas company	Moderate	Leverage AI-powered analysis of retinal imaging and real-world data to accelerate clinical development and personalize treatment for geographic atrophy.	parsippany, New Jersey
70	radim spa	Moderate	Leverage AI for accelerated drug discovery and predictive quality control to reduce time-to-market and improve manufacturing efficiency.	,
71	Vireo	Moderate		minneapolis, Minnesota
72	Rhino Linings	Moderate		San Diego, California
73	biogen	Moderate	AI can accelerate drug discovery and clinical trial design for complex neurological diseases by predicting drug-target interactions and identifying optimal patient cohorts.	cambridge, Massachusetts
74	incyte	Moderate	AI can accelerate oncology drug discovery by predicting compound efficacy and patient response biomarkers, dramatically reducing R&D timelines and costs.	wilmington, Delaware
75	TemperPack	Moderate		Richmond, Virginia
76	patheon	Moderate	AI can optimize end-to-end drug development and manufacturing processes, from predictive formulation design to real-time quality control, significantly reducing time-to-market and production costs for client therapies.	waltham, Massachusetts
77	ironshore	Moderate	Leveraging AI for accelerated drug discovery and clinical trial optimization to reduce time-to-market and R&D costs.	,
78	kelly engineering service at dow chemical	Moderate	AI-driven predictive maintenance and process optimization can significantly reduce unplanned downtime, improve yield, and enhance safety across large-scale chemical manufacturing complexes.	houston, Texas
79	mylan	Moderate	AI can optimize complex global supply chains and production schedules to reduce costs and prevent drug shortages.	canonsburg, Pennsylvania
80	alnylam pharmaceuticals	Moderate	AI can accelerate target identification and validation for RNAi therapeutics by analyzing multi-omics data to predict gene-disease associations and optimize siRNA design.	cambridge, Massachusetts
81	Fralock	Moderate		Santa Clarita, California
82	ecolab	Moderate	AI-powered predictive maintenance and chemical dosing for water treatment and cleaning systems, optimizing resource use and preventing equipment failures.	st. paul, Minnesota
83	catalent	Moderate	AI can optimize complex biologics manufacturing processes, predict batch failures, and accelerate formulation development, directly improving yield, quality, and time-to-market.	tampa, Florida
84	LIFOAM	Moderate		Greer, South Carolina
85	imclone systems, a wholly-owned subsidiary of eli lilly and company	Moderate	AI can accelerate oncology drug discovery and clinical trial design by predicting drug-target interactions and optimizing patient stratification for therapies like Erbitux.	,
86	Berkshire Corporation	Moderate		Great Barrington, Massachusetts
87	supernus pharmaceuticals, inc.	Moderate	Leveraging AI for drug discovery and clinical trial optimization to accelerate CNS pipeline development and reduce R&D costs.	rockville, Maryland
88	p&g chemicals	Moderate	AI-driven predictive modeling can optimize complex chemical synthesis processes, reducing energy consumption, minimizing waste, and accelerating R&D for new sustainable formulations.	cincinnati, Ohio
89	millennium pharmaceuticals, inc.	Moderate	AI-driven target discovery and patient stratification can dramatically accelerate the development of novel oncology therapies and improve clinical trial success rates.	cambridge, Massachusetts
90	Porex	Moderate		Fairburn, Georgia
91	sanofi-aventis u.s. llc	Moderate	AI can dramatically accelerate drug discovery and clinical trial design by predicting molecular interactions and optimizing patient recruitment, potentially cutting years and billions from R&D timelines.	bridgewater, New Jersey
92	viatris	Moderate	AI can optimize the end-to-end pharmaceutical supply chain, from predictive demand forecasting to dynamic inventory management, reducing costs and preventing drug shortages.	pittsburgh, Pennsylvania
93	Polytex	Moderate		Ponte Vedra, Florida
94	HellermannTyton	Moderate		Tlaquepaque, Jalisco
95	ColorMasters	Moderate		Albertville, Alabama
96	Nutraceutical	Moderate		Park City, Utah
97	ENTEK	Moderate		Lebanon, Oregon
98	Bgintr	Moderate		union, New Jersey
99	Sierra Nevada Corporation	Moderate		Sparks, Nevada
100	Kimia Farma Apotek	Moderate		Jakarta Special Capital Region, New York

See where your company ranks.

Get a private AI adoption assessment with actionable recommendations and deployment timeline.

Request Private Analysis →